Enhancing the Work of the Department of Health and Human Services National Vaccine Program in Global Immunization: Recommendations of the National Vaccine Advisory Committee

Global routine vaccination coverage, 2011 MMWR Morb Mortal Wkly Rep 2012; 61(43):883–5.

World Health Organization, UNICEF, The World Bank. State of the world's vaccines and immunization. 3rd ed. Geneva: WHO; 2009. Also available from: URL: http://whqlibdoc.who.int/publications/2009/9789241563864_eng.pdf [cited 2012 Aug 7].

Global Polio Eradication Initiative. Polio eradication and endgame strategic plan 2013–2018. Geneva: World Health Organization; 2013. Also available from: URL: http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/EndGameStratPlan_WHAversion.pdf [cited 2013 Jun 25].

Global control and regional elimination of measles, 2000–2011 [published erratum appears in MMWR Morb Mortal Wkly Rep 2013; 62(5):89]. MMWR Morb Mortal Wkly Rep 2013;62(2):27–31.

UNICEF. Elimination of maternal and neonatal tetanus [cited 2012 Nov 13]. Available from: URL: http://www.unicef.org/health/index_43509.html

Decade of Vaccines Collaboration. About us [cited 2012 Nov 14]. Available from: URL: http://www.dovcollaboration.org

Liu L Johnson HL Cousens S Perin J Scott S Lawn JE Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 Lancet 2012; 379:2151–61.

Lee LA Franzel L Atwell J Datta SD Friberg IK Goldie SJ The estimated mortality impact of vaccinations forecast to be administered during 2011–2020 in 73 countries supported by the GAVI Alliance. Vaccine 2013; 31 Suppl 2:B61–72.

Walker CL Rudan I Liu L Nair H Theodoratou E Bhutta ZA Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 381:1405–16.

Save the Children. Finding the final fifth: inequalities in immunisation. London: Save the Children; 2012.

Zaffran M Vandelaer J Kristensen D Melgaard B Yadav P Antwi-Agyei KO The imperative for stronger vaccine supply and logistics systems. Vaccine 2013; 31 Suppl 2:B73–80.

Wang SA Hyde TB Mounier-Jack S Brenzel L Favin M Gordon WS New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening. Vaccine 2013; 31 Suppl 2:B122–8.

Shearer JC Walker DG Risko N Levine OS . The impact of new vaccine introduction on the coverage of existing vaccines: a cross-national, multivariable analysis. Vaccine 2012; 30:7582–7.

Save the Children. Immunization for all: no child left behind. London: Save the Children; 2012.

Duclos P Okwo-Bele J-M Gacic-Dobo M Cherian T . Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights 2009; 9 Suppl 1:S2.

World Health Organization. Global vaccine safety blueprint—the landscape analysis. Geneva: WHO; 2012. Also available from: URL: http://whqlibdoc.who.int/hq/2012/WHO_IVB_12.04_eng.pdf [cited 2013 Mar 16].

Dabbagh A Eggers R Cochi S Dietz V Strebel P Cherian T . A new global framework for immunization monitoring and surveillance. Bull World Health Organ 2007; 85:904.

World Health Organization. Global framework for immunization monitoring and surveillance. Geneva: WHO; 2007. Also available from: URL: http://www.who.int/immunization/documents/WHO_IVB_07.06/en/index.html [cited 2013 Feb 17].

Chan M Lake A Fauci A . Decade of Vaccines Global Vaccine Action Plan, 2011–2020. Geneva: World Health Organization; 2013. Also available from: URL: http://www.dovcollaboration.org/action-plan [cited 2014 May 11].

Henry J . Kaiser Family Foundation. 2012 survey of Americans on the U.S. role in global health. 2012 [cited 2012 Nov 15]. Available from: URL: http://www.kff.org/kaiserpolls/upload/8304.pdf

Centers for Disease Control and Prevention (US). Measles still threatens health security: on 50th anniversary of measles vaccine, spike in imported measles cases [press release]; 2013 Dec 5 [cited 2014 Feb 24]. Available from: URL: http://www.cdc.gov/media/releases/2013/p1205-meales-threat.html

Orenstein WA . Supporting global immunization: a humanitarian interest and a self-interest. Infect Dis Child 2012; 25:32.

Ehreth J . The global value of vaccination. Vaccine 2003; 21:596–600.

Whitney CG Zhou F Singleton J Schuchat A . Benefits from immunization during the Vaccines for Children program era—United States, 1994–2013. MMWR Morb Mortal Wkly Rep 2014; 63(16):352–5.

Zhou F Shefer A Wenger J Messonnier M Wang LY Lopez A Economic evaluation of the routine childhood immunization program in the United States, 2009 Pediatrics 2014; 133:577–85.

Daulaire N . The importance of the global health strategy from the U.S. Department of Health and Human Services. Am J Trop Med Hyg 2012; 87:382–4.

Department of Health and Human Services (US). 2010 National Vaccine Plan [cited 2012 Nov 14]. Available from: URL: http://www.hhs.gov/nvpo/vacc_plan/2010Plan/nationalvaccineplan.pdf

Department of Health and Human Services (US). The global health strategy of the U.S. Department of Health and Human Services. 2011 [cited 2012 Nov 14]. Available from: URL: http://www.globalhealth.gov/pdfs/Global%20Health%20Strategy.pdf

Centers for Disease Control and Prevention (US). Global immunization strategic framework 2011–2015. Atlanta: CDC; 2011. Also available from: URL: http://www.cdc.gov/globalhealth/immunization/docs/gid-strat-framewk.pdf [cited 2012 Dec 6].

Department of Health and Human Services (US). The global health security agenda [cited 2014 May 17]. Available from: URL: http://www.globalhealth.gov/global-health-topics/global-health-security/ghsagenda.html

Department of Health and Human Services (US), National Vaccine Advisory Committee. Enhancing the work of the Department of Health and Human Services National Vaccine Program in global immunization: recommendations of the National Vaccine Advisory Committee. Public Health Rep 2014; 129(Suppl 3):12–85.

Global Polio Eradication Initiative Independent Monitoring Board. Polio's last stand? Report of the Independent Monitoring Board of the Global Polio Eradication Initiative. London: GPEI IMB; 2012. Also available from: URL: http://www.polioeradication.org/Portals/0/Document/Aboutus/Governance/IMB/7IMBMeeting/7IMB_Report_EN.pdf [cited 2012 Dec 2].

Global Polio Eradication Initiative. Financial resource requirements 2013–2018. Geneva: World Health Organization; 2013. Also available from: URL: http://www.polioeradication.org/Portals/0/Document/Financing/FRR_EN_A4.pdf [cited 2014 May 11].

MRI. The Measles and Rubella Initiative. 2012 [cited 2012 Aug 2]. Available from: URL: http://www.measlesinitiative.org

Increased transmission and outbreaks of measles—European region, 2011 MMWR Morb Mortal Wkly Rep 2011; 60(47):1605–10.

Thompson KM Tebbens RJ . Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Anal 2006; 26:1423–40.

Measles—United States, 2011 MMWR Morb Mortal Wkly Rep 2012; 61(15):253–7.

World Health Organization. The Global Vaccine Safety Initiative (GVSI) [cited 2013 Mar 16]. Available from: URL: http://www.who.int/vaccine_safety/initiative/en

Liu L Johnson HL Cousens S Perin J Scott S Lawn JE Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 Lancet 2012; 379:2151–61.

United Nations. Millennium development goals and beyond 2015: goal 4: reduce child mortality [cited 2013 Jun 26]. Available from: URL: http://www.un.org/millenniumgoals/childhealth.shtml

UNICEF. Committing to child survival: a promise renewed—progress report 2012 [cited 2012 Nov 21]. Available from: URL: http://www.un.org/ru/publications/pdfs/renewed_ progress report 2012.pdf

Department of Health and Human Services (US). The global health strategy of the U.S. Department of Health and Human Services. 2011 [cited 2012 Nov 14]. Available from: URL: http://www.globalhealth.gov/pdfs/Global%20Health%20Strategy.pdf

Department of Health and Human Services (US). 2010 National Vaccine Plan: protecting the nation's health through immunization [cited 2012 Nov 14]. Available from: URL: http://www.hhs.gov/nvpo/vacc_plan/2010 Plan/nationalvaccineplan.pdf

World Health Organization, UNICEF, World Bank. State of the world's vaccines and immunization. 3rd ed. Geneva: WHO; 2009.

Global routine vaccination coverage, 2011 MMWR Morb Mortal Wkly Rep 2012; 61(43):883–5.

Proceedings of the global technical consultation to assess the feasibility of measles eradication, 28–30 July 2010 J Infect Dis 2011;204 Suppl:S1–569.

Global measles mortality, 2000–2008. MMWR Morb Mortal Wkly Rep 2009; 58(47):1321–6.

Lozano R Naghavi M Foreman K Lim S Shibuya K Aboyans V Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 2012; 380:2095–128.

Global control and regional elimination of measles, 2000–2011 [published erratum appears in MMWR Morb Mortal Wkly Rep 2013; 62(5):89]. MMWR Morb Mortal Wkly Rep 2013;62(2):27–31.

Brown DW Burton A Gacic-Dobo M Karimov RI Vandelaer J Okwo-Bele JM . A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS). BMC Public Health 2011; 11:806.

Lee LA Franzel L Atwell J Datta SD Friberg IK Goldie SJ The estimated mortality impact of vaccinations forecast to be administered during 2011–2020 in 73 countries supported by the GAVI Alliance. Vaccine 2013; 31 Suppl 2:B61–72.

Walker CL Rudan I Liu L Nair H Theodoratou E Bhutta ZA Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 381:1405–16.

Deogaonkar R Hutubessy R van der Putten I Evers S Jit M . Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health 2012; 12:878.

Zhou F Santoli J Messonnier ML Yusuf HR Shefer A Chu SY Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001 Arch Pediatr Adolesc Med 2005; 159:1136–44.

Bloom D Canning D Weston M . The value of vaccination. World Econ 2005; 6:15–39.

UNICEF. 2012 vaccine projections: quantities and pricing [cited 2012 Dec 17]. Available from: URL: http://www.unicef.org/supply/files/2012_Vaccine_Projection_0504.pdf

Whitney CG Farley MM Hadler J Harrison LH Bennett NM Lynfield R Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737–46.

Levine OS Bloom DE Cherian T de Quadros C Sow S Wecker J The future of immunisation policy, implementation, and financing. Lancet 2011; 378:439–48.

Hanvoravongchai P Mounier-Jack S Oliveira Cruz V Balabanova D Biellik R Kitaw Y Impact of measles elimination activities on immunization services and health systems: findings from six countries. J Infect Dis 2011; 204 Suppl 1:S82–9.

Griffiths UK Mounier-Jack S Oliveira-Cruz V Balabanova D Hanvoravongchai P Ongolo P . How can measles eradication strengthen health care systems? J Infect Dis 2011; 204 Suppl 1:S78–81.

Olusanya BO . Optimising the use of routine immunisation clinics for early childhood development in sub-Saharan Africa. Vaccine 2009; 27:3719–23.

World Health Organization. The third ten years of the World Health Organization: 1968–1977. Geneva: WHO; 2008.

Andrus JK de Quadros CA Solórzano CC Periago MR Henderson DA . Measles and rubella eradication in the Americas. Vaccine 2011; 29 Suppl 4:D91–6.

De Quadros CA Andrus JK Danovaro-Holliday MC Castillo-Solórzano C . Feasibility of global measles eradication after interruption of transmission in the Americas. Expert Rev Vaccines 2008; 7:355–62.

American Red Cross, Centers for Disease Control and Prevention (US), and UNICEF. Measles and Rubella Initiative. 2012 [cited 2012 Aug 2]. Available from: URL: http://www.measlesinitiative.org

Centers for Disease Control and Prevention (US). Global health—polio: polio endgame and legacy [cited 2012 Dec 10]. Available from: URL: http://www.cdc.gov/polio/plan

Bloland P Simone P Burkholder B Slutsker L De Cock KM . The role of public health institutions in global health system strengthening efforts: the US CDC's perspective. PLoS Med 2012; 9:e1001199.

Duintjer Tebbens RJ Pallansch MA Cochi SL Wassilak SG Linkins J Sutter RW Economic analysis of the global polio eradication initiative. Vaccine 2010; 29:334–43.

Thompson KM Tebbens RJ . Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Anal 2006; 26:1423–40.

Measles—United States, 2011 MMWR Morb Mortal Wkly Rep 2012; 61(15):253–7.

Orenstein WA . Supporting global immunization: a humanitarian interest and a self-interest. Infect Dis Child 2012; 25:32.

Glassman A Zoloa JI Duran D . A commitment to vaccination index—measuring government progress toward global immunization. CDC Policy Paper 009. Atlanta: Centers for Disease Control and Prevention (US); 2012.

Lydon P Beyai PL Chaudhri I Cakmak N Satoulou A Dumolard L . Government financing for health and specific national budget lines: the case of vaccines and immunization. Vaccine 2008; 26:6727–34.

World Health Organization, UNICEF, Centers for Disease Control and Prevention (US), and Rotary International. Global Polio Eradication Initiative. 2012 [cited 2012 Nov 13]. Available from: URL: http://www.polioeradication.org

World Health Organization and PATH. The Meningitis Vaccine Project. 2012 [cited 2012 Nov 13]. Available from: URL: http://www.meningvax.org

UNICEF. Elimination of maternal and neonatal tetanus [cited 2012 Nov 13]. Available from: URL: http://www.unicef.org/health/index_43509.html

Global Alliance for Vaccines and Immunizations. The GAVI Alliance [cited 2012 Nov 18]. Available from: URL: http://www.gavialliance.org

World Health Organization, UNICEF. Global immunization vision and strategy, 2006–2015. Geneva: WHO; 2005. Also available from: URL: http://whqlibdoc.who.int/hq/2005/WHO_IVB_05.05.pdf [cited 2012 Nov 20].

Decade of Vaccines Collaboration. About us [cited 2012 Nov 14]. Available from: URL: http://www.dovcollaboration.org

World Health Organization, Sixty-fourth World Health Assembly. Global immunization vision and strategy—progress report and strategic direction for the Decade of Vaccines. 2011 [cited 2012 Nov 20]. Available from: URL: http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_14-en.pdf

Decade of Vaccines Collaboration. Global vaccine action plan: 2011–2020. Geneva: World Health Organization; 2013. Also available from: URL: http://www.dovcollaboration.org/action-plan [cited 2012 Nov 20].

Duclos P Okwo-Bele J-M Gacic-Dobo M Cherian T . Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights 2009; 9 Suppl 1:S2.

Kim-Farley RJ . EPI for the 1990s. The Expanded Programme on Immunization Team. Vaccine 1992; 10:940–8.

Hajjeh R . Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type B vaccine experience. Philos Trans R Soc London 2011; 366:2827–32.

Levine OS Cherian T Hajjeh R Knoll MD . Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries. Clin Infect Dis 2009; 48 Suppl 2:S33–6.

GAVI Alliance. GAVI Alliance progress report 2011. Geneva: GAVI Alliance; 2011.

Henry J . Kaiser Family Foundation. 2012 survey of Americans on the U.S. role in global health. 2012 [cited 2012 Nov 15]. Available from: URL: http://www.kff.org/kaiserpolls/upload/8304.pdf

Henry J . Kaiser Family Foundation. Budget tracker: status of U.S. funding for key global health accounts [cited 2012 Dec 5]. Available from: URL: http://kff.org/global-health-policy/fact-sheet/budget-tracker-status-of-u-s-funding-for-key-global-health-accounts/

U.S. Agency for International Development. Congressional budget justification [cited 2012 Dec 5]. Available from: URL: http://www.usaid.gov/results-and-data/budget-spending/congressional-budget-justification

Centers for Disease Control and Prevention (US). Fiscal year 2009: justification of estimates for appropriation committees [cited 2012 Dec 5]. Available from: URL: http://www.cdc.gov/fmo/topic/budget information/appropriations_budget_form_pdf/fy09_cdc_cj_final.pdf

Centers for Disease Control and Prevention (US). Fiscal year 2010: justification of estimates for appropriation committees [cited 2014 May 10]. Available from: URL: http://www.cdc.gov/fmo/topic/budget information/appropriations_budget_form_pdf/fy2010_cdc_cj_final.pdf

Centers for Disease Control and Prevention (US). Fiscal year 2011: justification of estimates for appropriation committees [cited 2014 May 10]. Available from: URL: http://www.cdc.gov/fmo/topic/budget information/appropriations_budget_form_pdf/fy2011_cdc_cj_final.pdf

Centers for Disease Control and Prevention (US). Fiscal year 2013: justification of estimates for appropriation committees [cited 2014 May 10]. Available from: URL: http://www.cdc.gov/fmo/topic/Budget Information/appropriations_budget_form_pdf/FY2013_CDC_CJ_Final.pdf

Centers for Disease Control and Prevention (US). Global immunization strategic framework 2011–2015 [cited 2012 Dec 6]. Available from: URL: http://www.cdc.gov/globalhealth/gid/framework

Centers for Disease Control and Prevention (US). Winnable battles—global immunization [cited 2014 Apr 16]. Available from: URL: http://www.cdc.gov/winnablebattles/globalimmunization/index.html

Centers for Disease Control and Prevention (US). Polio: unprotected story [cited 2012 Aug 8]. Available from: URL: http://www.cdc.gov/VACCINES/vpd-vac/polio/unprotected-story.htm

Moss WJ Griffin DE . Measles. Lancet 2012; 379:153–64.

Orenstein WA Maldonado YA . We're 99% there: now is the time for final push to end polio forever. AAP News 2012; 33:1.

John TJ . Poliomyelitis in India: prospects and problems of control. Rev Infect Dis 1984; 6 Suppl 2:S438–41.

Kew O . Reaching the last one per cent: progress and challenges in global polio eradication. Curr Opin Virol 2012; 2:188–98.

Progress toward global eradication of poliomyelitis, 2002 MMWR Morb Mortal Wkly Rep 2003; 52(16):366–9.

Aylward B Tangermann R . The global polio eradication initiative: lessons learned and prospects for success. Vaccine 2011; 29 Suppl 4:D80–5.

World Heath Organization. Progress towards interrupting wild poliovirus transmission worldwide: January 2010-March 2011 Wkly Epidemiol Rec 2011; 86:189–204.

Global Polio Eradication Initiative. Polio this week. 2014 [cited 2014 Feb 24]. Available from: URL: http://www.polioeradication.org/Dataandmonitoring/poliothisweek.aspx

Olufowote JO . Local resistance to the global eradication of polio: newspaper coverage of the 2003–2004 vaccination stoppage in northern Nigeria. Health Commun 2011; 26:743–53.

McNeil DG Jr . C.I.A. vaccine ruse in Pakistan may have harmed the war on polio. The New York Times 2012 Jul 9 [cited 2012 Dec 10]. Available from: URL: http://www.nytimes.com/2012/07/10/health/cia-vaccine-ruse-in-pakistan-may-have-harmed-polio-fight.html?pagewanted=all

Larson HJ Paterson P . Eradicating polio: persisting challenges beyond endemic countries. Expert Rev Vaccines 2011; 10:1635–6.

Park M . Taliban's vaccine ban may affect 280,000 children. CNN 2012 Jul 17 [cited 2012 Aug 7]. Available from: URL: http://articles.cnn.com/2012-07-17/asia/world_asia_pakistan-taliban-polio-vaccine_1_polio-vaccines-polio-campaign-drone-strikes

Walther C . Eradicating polio in Afghanistan takes persuasion, participation and peace [cited 2013 Jul 27]. Available from: URL: http://www.unicef.org/infobycountry/afghanistan_51171.html

Progress toward poliomyelitis eradication—Afghanistan and Pakistan, January 2011-August 2012 MMWR Morb Mortal Wkly Rep 2012; 61(39):790–5.

Progress toward poliomyelitis eradication—Nigeria, January 2011-September 2012 MMWR Morb Mortal Wkly Rep 2012; 61(44):899–904.

Progress toward poliomyelitis eradication—Chad, January 2011-August 2012 MMWR Morb Mortal Wkly Rep 2012; 61(42):858–62.

UNICEF, World Health Organization. Immunization summary—a statistical reference containing data through 2010. Geneva: WHO; 2012.

Outbreaks following wild poliovirus importations—Europe, Africa, and Asia, January 2009-September 2010 MMWR Morb Mortal Wkly Rep 2010; 59(43):1393–9.

Independent Monitoring Board of the GPEI. Polio's last stand? Report of the Independent Monitoring Board of the Global Polio Eradication Initiative. 2012 [cited 2012 Dec 2]. Available from: URL: http://www.polioeradication.org/Portals/0/Document/Aboutus/Governance/IMB/7IMBMeeting/7IMB_Report_EN.pdf

World Health Organization. International travel and health, 2012 edition: chapter 6: vaccine-preventable diseases and vaccines. Geneva: WHO; 2012. Also available from: URL: http://www.who.int/ith/chapters/ith2012en_chap6.pdf [cited 2013 Jun 23].

Global Polio Eradication Initiative. Every last child—Global Polio Eradication Initiative strategic plan 2010–2012. Geneva: World Health Organization; 2010.

Global Polio Eradication Initiative. Polio eradication and endgame strategic plan 2013–2018. Geneva; World Health Organization; 2013. Also available from: URL: http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/EndGame StratPlan_WHAversion.pdf [cited 2013 Jun 25].

Plotkin SA Orenstein WA Offit PA . Vaccines. 5th ed. Philadelphia: Saunders Elsevier; 2008.

Alexander JP Ehresmann K Seward J Wax G Harriman K Fuller S Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. J Infect Dis 2009; 199:391–7.

Update on vaccine-derived polioviruses—worldwide, April 2011- June 2012 MMWR Morb Mortal Wkly Rep 2012; 61(37):741–6.

World Health Organization. Meeting of the strategic advisory group of experts on immunization, November 2012—conclusions and recommendations. Wkly Epidemiol Rec 2013; 88:1–16.

Centers for Disease Control and Prevention (US). Updates on CDC's polio eradication efforts. 2013 [cited 2013 Jun 27]. Available from: URL: http://www.cdc.gov/polio/updates

Global Polio Eradication Initiative. Polio: global emergency action plan 2012–2013: action to stop polio now in Nigeria, Pakistan and Afghanistan. Geneva: World Health Organization; 2012. Also available from: URL: http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/EAP_201205.pdf [cited 2013 Jun 29].

Global Polio Eradication Initiative. Financial resource requirements 2013–2018. Geneva: World Health Organization; 2013. Also available from: URL: http://www.polioeradication.org/Portals/0/Document/Financing/FRR_EN_A4.pdf [cited 2014 May 11].

Bakker WA Thomassen YE van't Oever AG Westdijk J van Oijen MG Sundermann LC Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. Vaccine 2011; 29:7188–96.

Hickling J Jones R Nundy N Zehrung D . Improving the affordability of inactivated poliovirus vaccines (IPV) for use in low- and middle-income countries: an economic analysis of strategies to reduce the cost of routine IPV immunization. Seattle: PATH; 2010. Also available from: URL: http://www.path.org/publications/detail.php?i=1809 [cited 2013 Aug 22].

Emory University Vaccine Center. Scientific declaration on polio eradication [cited 2013 Jun 22]. Available from: URL: http://www.vaccines.emory.edu/poliodeclaration

Bhutta ZA Orenstein WA . Scientific declaration on polio eradication. Vaccine 2013; 31:2850–1.

Global Polio Eradication Initiative. Financing [cited 2013 May 22]. Available from: URL: http://www.polioeradication.org/financing.aspx

World Health Organization. Global Polio Eradication Initiative: 6th meeting of the Independent Monitoring Board. Wkly Epidemiol Rec 2012; 87:241–3.

Thompson KM Tebbens RJD . Eradication versus control for poliomyelitis: an economic analysis. Lancet 2007; 369:1363–71.

Measles and Rubella Initiative. Featured content [cited 2–14 Apr 16]. Available from: URL: http://www.measlesrubellainitiative.org/

Otten M Kezaala R Fall A Masresha B Martin R Cairns L Public-health impact of accelerated measles control in the WHO African Region 2000-03. Lancet 2005; 366:832–9.

Rubella vaccines: WHO position paper. Wkly Epidemiol Rec 2011; 86:301–16.

Global Measles and Rubella Laboratory Network, January 2004-June 2005 MMWR Morb Mortal Wkly Rep 2005; 54(43):1100–4.

Robertson SE Featherstone DA Gacic-Dobo M Hersh BS . Rubella and congenital rubella syndrome: global update. Rev Pan Am Salud Publica 2003; 14:306–15.

World Health Organization. Global eradication of measles: report by the Secretariat. 2010 [cited 2012 Aug 2]. Available from: URL: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_18-en.pdf

UNICEF, World Health Organization. Immunization summary: a statistical reference containing data through 2009. Geneva: WHO; 2011. Also available from: URL: http://www.childinfo.org/files/32775_UNICEF.pdf [cited 2012 Aug 4].

Global measles mortality, 2000–2008. MMWR Morb Mortal Wkly Rep 2009; 58(47):1321–6.

Christie A Gay A . Measles eradication. Lancet 2011; 377:807–8.

Strebel PM Cochi SL Hoekstra E Rota PA Featherstone D Bellini WJ A world without measles. J Infect Dis 2011;204 Suppl:S1-3.

European Centre for Disease Prevention and Control. European monthly measles monitoring (EMMO). Stockholm (Sweden): European Centre for Disease Prevention and Control; February 2012. Also available from: URL: http://ecdc.europa.eu/en/publications/publications/sur_emmo_european-monthly-measles-monitoring-february-2012.pdf [cited 2013 Jun 26].

Increased transmission and outbreaks of measles—European region, 2011 MMWR Morb Mortal Wkly Rep 2011; 60(47):1605–10.

World Health Organization. WHO recommendations for routine immunization—summary tables [cited 2014 May 10]. Available from: URL: http://www.who.int/immunization/policy/immunization_tables/en

World Health Organization. Measles outbreaks and progress towards meeting measles pre-elimination goals: WHO African Region, 2009–2010. Wkly Epidemiol Rec 2011; 86:129–40.

Larson H Brocard Paterson P Erondu N . The globalization of risk and risk perception: why we need a new model of risk communication for vaccines. Drug Saf 2012; 35:1053–9.

Poethko-Müller C Ellert U Kuhnert R Neuhauser H Schlaud M Schenk L . Vaccination coverage against measles in German-born and foreign-born children and identification of unvaccinated subgroups in Germany. Vaccine 2009; 27:2563–9.

The Global Polio Eradication Initiative Stop Transmission of Polio (STOP) program—1999-2013. MMWR Morb Mortal Wkly Rep 2013; 62(24):501–3.

Centers for Disease Control and Prevention (US). Global health—global immunization: Stop Transmission of Polio (STOP) program [cited 2013 Jun 26]. Available from: URL: http://www.cdc.gov/polio/stop

Burton A Monasch R Lautenbach B Gacic-Dobo M Neill M Karimov R WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009; 87:535–41.

UNICEF. WHO-UNICEF joint reporting: immunization statistics. 2013 [cited 2013 Aug 4]. Available from: URL: http://www.unicef.org/immunization/index_statistics.html

Save the Children. Vaccines for all: help save 4 million lives by 2015. London: Save the Children; 2011.

World Health Organization. Immunization surveillance, assessment and monitoring. 2013 [cited 2013 Aug 4]. Available from: URL: http://www.who.int/immunization_monitoring/routine/joint_reporting/en/index.html

UNICEF. Statistics and monitoring: multiple indicator cluster survey (MICS) [cited 2013 Feb 27]. Available from: URL: http://www.unicef.org/statistics/index_24302.html

Borgdorff MW Walker GJ . Estimating vaccination coverage: routine information or sample survey? J Trop Med Hyg 1988; 91:35–42.

Huhn GD Brown J Perea W Berthe A Otero H LiBeau G Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons—Liberia, 2004 Vaccine 2006; 24:730–7.

Lim SS Stein DB Charrow A Murray CJL . Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lancet 2008; 372:2031–46.

Murray CJ Shengelia B Gupta N Moussavi S Tandon A Thieren M . Validity of reported vaccination coverage in 45 countries. Lancet 2003; 362:1022–7.

Save the Children. Finding the final fifth: inequalities in immunisation. London: Save the Children; 2012.

Miles M Ryman TK Dietz V Zell E Luman ET . Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine 2013; 31:1560–8.

Zuber PL Yaméogo KR Yaméogo A Otten MW Jr . Use of administrative data to estimate mass vaccination campaign coverage, Burkina Faso, 1999. J Infect Dis 2003; 187 Suppl 1:S86–90.

Hardon A Blume S . Shifts in global immunisation goals (1984–2004): unfinished agendas and mixed results. Soc Sci Med 2005; 60:345–56.

Starling M Brugha R Walt G . New products into old systems: the Global Alliance for Vaccines and Immunization (GAVI) from a country perspective. London: Save the Children; 2002. Also available from: URL: http://www.eldis.org/vfile/upload/1/document/0708/DOC11488.pdf [cited 2013 Jul 28].

Mavimbe JC Braa J Bjune G . Assessing immunization data quality from routine reports in Mozambique. BMC Public Health 2005; 5:108.

Onta SR Sabroe S Hansen EH . The quality of immunization data from routine primary health care reports: a case from Nepal. Health Policy Plan 1998; 13:131–9.

Haddad S Bicaba A Feletto M Fournier P Zunzunegui MV . Heterogeneity in the validity of administrative-based estimates of immunization coverage across health districts in Burkina Faso: implications for measurement, monitoring and planning. Health Policy Plan 2010; 25:393–405.

Papania M Rodewald L . For better immunisation coverage, measure coverage better. Lancet 2006; 367:965–6.

Weeks RM Svetlana F Noorgoul S Valentina G . Improving the monitoring of immunization services in Kyrgyzstan. Health Policy Plan 2000; 15:279–86.

Williamson L Stoops N Heywood A . Developing a district health information system in South Africa: a social process or technical solution? Stud Health Technol Inform 2001; 84(Pt 1):773–7.

GAVI Alliance. Measure what you manage: the data quality challenge. 2012 [cited 2014 May 15]. Available from: URL: http://www.gavialliance.org/library/pf2012-sessions/23-%E2%80%93-measure-what-you-manage-the-data-quality-challenge/

Health Metrics Network. Assessing the national health information system: an assessment tool, version 4.00. Geneva: World Health Organization; 2008.

Carolina Population Center. MEASURE evaluation: data quality assurance [cited 2013 Apr 8]. Available from: URL: http://www.cpc.unc.edu/measure/tools/monitoring-evaluation-systems/data-quality-assurance-tools

Luman ET Ryman TK Sablan M . Estimating vaccination coverage: validity of household-retained vaccination cards and parental recall. Vaccine 2009; 27:2534–9.

United Nations. Designing household survey samples: practical guidelines. New York: United Nations Publications; 2008.

The DHS Program. Demographic and health survey (DHS) overview [cited 2013 Jul 29]. Available from: URL: http://www.measuredhs.com/What-We-Do/Survey-Types/DHS.cfm

The DHS Program. DHS methodology [cited 2013 Jul 29]. Available from: URL: http://www.measuredhs.com/What-We-Do/Survey-Types/DHS-Methodology.cfm

Ronveaux O Rickert D Hadler S Groom H Lloyd J Bchir A The immunization data quality audit: verifying the quality and consistency of immunization monitoring systems. Bull World Health Organ 2005; 83:503–10.

Brown J Monasch R Bicego G Burton A Boerma JT . An assessment of the quality of national child immunization coverage estimates in population-based surveys. Chapel Hill (NC): Carolina Population Center; 2002. Also available from: URL: http://pdf.usaid.gov/pdf_docs/pnacq365.pdf [cited 2014 Feb 24].

Langsten R Hill K . The accuracy of mothers' reports of child vaccination: evidence from rural Egypt. Soc Sci Med 1998; 46:1205–12.

International Federation of Red Cross and Red Crescent Societies. Rapid Mobile Phone-based (RAMP) survey. 2014 [cited 2014 May 10]. Available from: URL: http://www.ifrc.org/ramp

International Federation of Red Cross and Red Crescent Societies. Rapid Mobile Phone-based (RAMP) survey: an innovation for health surveys. Geneva: International Federation of Red Cross and Red Crescent Societies; 2012. Also available from: URL: http://www.ifrc.org/PageFiles/96432/1226800-case study-Ramp-A4-EN_LR.pdf [cited 2013 Aug 23].

Centers for Disease Control and Prevention (US). Global vaccines and immunization [cited 2014 Apr 16]. Available from: URL: http://www.cdc.gov/globalhealth/immunization/routine/why.htm

Smith J Leke R Adams A Tangermann RH . Certification of polio eradication: process and lessons learned. Bull World Health Organ 2004; 82:24–30.

Danel I . Pakistan's public health surveillance system: a call to action. Geneva: World Health Organization; 2005.

St. Louis M . Global health surveillance. MMWR Surveill Summ 2012; 61(03):15–9.

World Health Organization. Integrated disease surveillance in the African Region—a regional strategy for communicable diseases 1999–2003. Zimbabwe (Zimbabwe (Africa): WHO Regional Office for Africa; 2001.

World Health Organization. Global framework for immunization monitoring and surveillance. Geneva: WHO; 2007. Also available from: URL: http://www.who.int/immunization/documents/WHO_IVB_07.06/en/index.html [cited 2013 Feb 17].

Dabbagh A Eggers R Cochi S Dietz V Strebel P Cherian T . A new global framework for immunization monitoring and surveillance. Bull World Health Organ 2007; 85:904.

Acute flaccid paralysis surveillance: a global platform for detecting and responding to priority infectious diseases. Wkly Epidemiol Rec 2004; 79:425–32.

World Health Organization. Acute flaccid paralysis (AFP) surveillance: the surveillance strategy for poliomyelitis eradication. Wkly Epidemiol Rec 1998; 73:113–7.

Global Polio Eradication Initiative. The Global Polio Laboratory Network (GPLN) [cited 2013 Feb 24]. Available from: URL: http://www.polioeradication.org/Dataandmonitoring/Surveillance/Global PolioLaboratoryNetwork.aspx

Developing and expanding contributions of the global laboratory network for poliomyelitis eradication, 1997–1999. MMWR Morb Mortal Wkly Rep 2000; 49(08):156–60.

Featherstone D Brown D Sanders R . Development of the Global Measles Laboratory Network. J Infect Dis 2003; 187 Suppl 1:S264–9.

Featherstone DA Rota PA Icenogle J Mulders MN Jee Y Ahmed H Expansion of the global measles and rubella laboratory network 2005-09. J Infect Dis 2011; 204 Suppl 1:S491–8.

World Health Organization. Global rotavirus information and surveillance bulletin reporting period: January through December 2008 Volume 1: December 2009. 2009 [cited 2014 Apr 16]. Available from: URL: http://www.who.int/immunization/diseases/rotavirus/Bulletin_Rota_Dec_09.pdf

Acute flaccid paralysis surveillance systems for expansion to other diseases, 2003–2004. MMWR Morb Mortal Wkly Rep 2004; 53(47):1113–6.

Heymann DL Aylward RB . Poliomyelitis eradication and pandemic influenza. Lancet 2006; 367:1462–4.

Nsubuga P McDonnell S Perkins B Sutter R Quick L White M Polio eradication initiative in Africa: influence on other infectious disease surveillance development. BMC Public Health 2002; 2:27.

World Health Organization Regional Office for Africa. Forty-eighth session of the WHO Regional Committee for Africa held in Harare, Zimbabwe, from 31 August to 4 September 1998: final report. Harare (ZiHarare (Zimbabwe): WHO; 1998. Also available from: URL: http://afrolib.afro.who.int/RC/en/AFR_RC48.pdf [cited 2013 Feb 25].

Perry HN McDonnell SM Alemu W Nsubuga P Chungong S Otten MW Jr Planning an integrated disease surveillance and response system: a matrix of skills and activities. BMC Med 2007; 5:24.

World Health Organization Regional Office for Africa. International health regulations (2005): Addis Ababa, Ethiopia [cited 2014 Apr 16]. Available from: URL: http://www.afro.who.int/en/search.html?searchword=AFR/RC56/INF.DOC/2&ordering=&searchphrase=all

Novak RT Kambou JL Diomandé FV Tarbangdo TF Ouédraogo-Traoré R Sangaré L Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis 2012; 12:757–64.

O'Brien KL Wolfson LJ Watt JP Henkle E Deloria-Knoll M McCall N Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893–902.

Watt JP Wolfson LJ O'Brien KL Henkle E Deloria-Knoll M McCall N Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009; 374:903–11.

Knoll MD Moïsi JC Muhib FB Wonodi CB Lee EH Grant L Standardizing surveillance of pneumococcal disease. Clin Infect Dis 2009; 48 Suppl 2:S37–48.

World Health Organization. Global invasive bacterial diseases (IBD) information and surveillance bulletin reporting period: January through December 2008, volume 1: December 2009 [cited 2014 Apr 16]. Available from: URL: http://www.who.int/nuvi/surveillance/Bulletin_IBD_Dec_09.pdf

World Health Organization. Measuring impact of Streptococcus pneumoniae and Haemophilus influenzae type b conjugate vaccination. Geneva: WHO; 2012. Also available from: URL: http://apps.who.int/iris/bitstream/10665/75835/1/WHO_IVB_12.08_eng.pdf [cited 2013 May 21].

World Health Organization. Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains. Geneva: WHO; 2008. Also available from: URL: http://whqlibdoc.who.int/hq/2008/WHO_IVB_08.16_eng.pdf [cited 2013 May 21].

Expanding poliomyelitis and measles surveillance networks to establish surveillance for acute meningitis and encephalitis syndromes—Bangladesh, China, and India, 2006–2008. MMWR Morb Mortal Wkly Rep 2012; 61(49):1008–11.

Touch S Grundy J Hills S Rani M Samnang C Khalakdina A The rationale for integrated childhood meningoencephalitis surveillance: a case study from Cambodia. Bull World Health Organ 2009; 87:320–4.

Hajjeh RA Privor-Dumm L Edmond K O'Loughlin R Shetty S Griffiths UK Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. Vaccine 2010; 28:7123–9.

Centers for Disease Control and Prevention (US). CDC global disease detection and emergency response [cited 2013 Jul 20]. Available from: URL: www.cdc.gov/globalhealth/gdder

Centers for Disease Control and Prevention (US). Global disease detection and emergency response activities at CDC, 2012 [cited 2013 Mar 2]. Available from: URL: http://www.cdc.gov/globalhealth/GDDER/pdf/gdder_report2012.pdf

World Health Organization. Everybody's business: strengthening health systems to improve health outcomes—WHO'S framework for action. Geneva: WHO; 2007. Also available from: URL: http://www.who.int/healthsystems/strategy/everybodys_business.pdf [2013 Mar 3].

Nsubuga P Nwanyanwu O Nkengasong JN Mukanga D Trostle M . Strengthening public health surveillance and response using the health systems strengthening agenda in developing countries. BMC Public Health 2010; 10 Suppl 1:S5.

Centers for Disease Control and Prevention (US). Field Epidemiology Training Program (FETP) [cited 2013 Jul 21]. Available from: URL: http://www.cdc.gov/globalhealth/FETP

Bhatnagar T Gupte MD Hutin YJ Kaur P Kumaraswami V Manickam P Seven years of the Field Epidemiology Training Programme (FETP) at Chennai, Tamil Nadu, India: an internal evaluation. Hum Resour Health 2012; 10:36.

López A Cáceres VM . Central America Field Epidemiology Training Program (CA FETP): a pathway to sustainable public health capacity development. Hum Resour Health 2008; 6:27.

TEPHINET. TEPHINET: Training Programs in Epidemiology and Public Health Interventions Network [cited 2014 May 10]. Available from: URL: http://www.tephinet.org

TEPHINET. TEPHINET 15th anniversary report 1997–2012. Decatur (GA): TEPHINET; 2012.

AFENET. AFENET: African Field Epidemiology Network [cited 2014 May 10]. Available from: URL: http://www.tephinet.org

Save the Children. Immunization for all: no child left behind. London: Save the Children; 2012.

Minh Thang N Bhushan I Bloom E Bonu S . Child immunization in Vietnam: situation and barriers to coverage. J Biosoc Sci 2007; 39:41–58.

Schelling E Bechir M Abdoulaye A Wyss K Randolph TF Zinsstag J . Human and animal vaccination delivery to remote nomadic families, Chad. Emerg Infect Dis 2007; 13:373–9.

Toikilik S Tuges G Lagani J Wafiware E Posanai E Coghlan B Are hard-to-reach populations being reached with immunization services? Findings from the 2005 Papua New Guinea national immunization coverage survey. Vaccine 2010; 28:4673–9.

UNICEF. Vaccinating the hard-to-reach. 2012 [cited 2014 Apr 16]. Available from: URL: http://www.unicef.org/immunization/index_hardtoreach.html

Vandelaer J Bilous J Nshimirimana D . Reaching Every District (RED) approach: a way to improve immunization. Bull World Health Organ 2008; 86:A–B.

Victora CG Huicho L Amaral JJ Armstrong-Schellenberg J Manzi F Mason E Are health interventions implemented where they are most needed? District uptake of the integrated management of childhood illness strategy in Brazil, Peru and the United Republic of Tanzania. Bull World Health Organ 2006; 84:792–801.

Uddin MJ Larson CP Oliveras E Khan AI Quaiyum MA Chandra Saha N . Child immunization coverage in rural hard-to-reach Haor areas of Bangladesh: possible alternative strategies. Asia Pac J Public Health 2009; 21:8–18.

Agarwal S Bhanot A Goindi G . Understanding and addressing childhood immunization coverage in urban slums. Indian Pediatr 2005; 42:653–63.

Schilderman T . Strengthening the knowledge and information systems of the urban poor. London: Department for International Development; 2002.

Uddin MJ Larson CP Oliveras E Khan AI Quaiyum MA Saha NC . Child immunization coverage in urban slums of Bangladesh: impact of an intervention package. Health Policy Plan 2010; 25:50–60.

Sheik-Mohamed A Velema JP . Where health care has no access: the nomadic populations of sub-Saharan Africa. Trop Med Int Health 1999; 4:695–707.

Zinsstag J Ould Taleb M Craig PS . Editorial: health of nomadic pastoralists: new approaches towards equity effectiveness. Trop Med Int Health 2006; 11:565–8.

Cliff JL Noormahomed AR . The impact of South African destabilization on maternal and child health in Mozambique. J Trop Pediatr 1988; 34:329–30.

Rubenstein LS . PeaceBrief: defying expectations: polio vaccination programs amid political and armed conflict. Washington: Institute of Peace (US); 2010.

Yach D . The impact of political violence on health and health services in Cape Town, South Africa, 1986: methodological problems and preliminary results. Am J Public Health 1988; 78:772–6.

Hoffman MN Klopper JM Disler PB Yach D . “Unrest”—a vital community health issue. S Afr Med J 1986; 70:213–3.

Gayer M Legros D Formenty P Connolly MA . Conflict and emerging infectious diseases. Emerg Infect Dis 2007; 13:1625–31.

Walsh D McNeil DG Jr . Female vaccination workers, essential in Pakistan, become prey. The New York Times 2012 Dec 20 [2013 Feb 25]. Available from: URL: http://www.nytimes.com/2012/12/21/world/asia/un-halts-vaccine-work-in-pakistan-after-more-killings.html?pagewanted=all&_r=2&

World Health Organization, UNICEF. Microplanning for immunization service delivery using the Reaching Every District (RED) strategy. Geneva: WHO; 2009. Also available from: URL: http://epi.swala.org/sites/default/files/9-WHO-RED-Microplanning-detailed-guide_0.pdf [cited 2014 May 10].

World Health Organization Regional Office for Africa. Immunization and vaccination development: Reach Every District (RED) approach. 2009 [cited 2014 May 10]. Available from: URL: http://www.who.int/immunization/funding/03_WHO_AFRO_IVD_RED.pdf

Ryman T Macauley R Nshimirimana D Taylor P Shimp L Wilkins K . Reaching Every District (RED) approach to strengthen routine immunization services: evaluation in the African region, 2005. J Public Health (Oxf) 2010; 32:18–25.

Macauley R Onyeze A Dicko M Kamwa M Mihigo R Ntsama B In-depth evaluation of the Reaching Every District approach in the African region. Brazzaville (Africa): World Health Organization Regional Office for Africa; 2007. Also available from: URL: http://www.immunizationbasics.jsi.com/Docs/AFRO_RED_Eval_Dec07.pdf [cited 2012 Nov 18].

Ryman TK Trakroo A Wallace A Gupta SK Wilkins K Mehta P Implementation and evaluation of the Reaching Every District (RED) strategy in Assam, India, 2005–2008. Vaccine 2011; 29:2555–60.

Centers for Disease Control and Prevention (US). Epidemiology of the unimmunized child: findings from the peer-reviewed published literature, 1999–2009. Atlanta: CDC; 2009. Also available from: URL: http://www.who.int/immunization/sage/CDC_UNVACC_REPORT_FINAL_v2.pdf [cited 2013 Jul 22].

Kouadio IK Kamigaki T Oshitani H . Measles outbreaks in displaced populations: a review of transmission, morbidity and mortality associated factors. BMC Int Health Hum Rights 2010; 10:5.

Luman ET Dietz V Andrus JK Binkin N , editors. Building on success: should other health services be integrated into the immunization platform? J Infect Dis 2012; 205(Suppl 1):S1–141.

Kamugisha C Cairns KL Akim C . An outbreak of measles in Tanzanian refugee camps. J Infect Dis 2003; 187 Suppl 1:S58–62.

Connolly MA Gayer M Ryan MJ Salama P Spiegel P Heymann DL . Communicable diseases in complex emergencies: impact and challenges. Lancet 2004; 364:1974–83.

Gracey M . Caring for the health and medical and emotional needs of children of migrants and asylum seekers. Acta Paediatr 2004; 93:1423–6.

Schwarzwald H . Illnesses among recently immigrated children. Semin Pediatr Infect Dis 2005; 16:78–83.

Phillips CB Benson J . Better primary health care for refugees—catch up immunisation. Aust Fam Physician 2007; 36:440–2, 444.

Toole MJ Waldman RJ . The public health aspects of complex emergencies and refugee situations. Annu Rev Public Health 1997; 18:283–312.

Toole MJ Steketee RW Waldman RJ Nieburg P . Measles prevention and control in emergency settings. Bull World Health Organ 1989; 67:381–8.

World Health Organization, UNICEF. WHO/UNICEF joint statement on reducing measles mortality in emergencies. 2004 [cited 2014 Apr 18]. Available from: URL: http://www.who.int/immunization/diseases/WHO_UNICEF_Measles_Emergencies.pdf

Paquet C . Vaccination in emergencies. Vaccine 1999; 17 Suppl 3:S116–9.

Paquet C Hanquet G . Control of infectious diseases in refugee and displaced populations in developing countries. Bull Inst Pasteur 1998; 96:3–14.

Zetter R Deikun G . Meeting humanitarian challenges in urban areas. Forced Migr Rev 2010; 34:5–7.

Kouadio IK Koffi AK Attoh-Toure H Kamigaki T Oshitani H . Outbreak of measles and rubella in refugee transit camps. Epidemiol Infect 2009; 137:1593–601.

Haelterman E Boelaert M Suetens C Blok L Henkens M Toole MJ . Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp. Trop Med Int Health 1996; 1:385–92.

Hindiyeh MY Aboudy Y Wohoush M Shulman LM Ram D Levin T Characterization of large mumps outbreak among vaccinated Palestinian refugees. J Clin Microbiol 2009; 47:560–5.

Measles among U.S.-bound refugees from Malaysia—California, Maryland, North Carolina, and Wisconsin, August-September 2011 MMWR Morb Mortal Wkly Rep 2011; 60(37):1281–2.

Coleman MS Garbat-Welch L Burke H Weinberg M Humbaugh K Tindall A Direct costs of a single case of refugee-imported measles in Kentucky. Vaccine 2012; 30:317–21.

Martin DC Yankay JE . Refugees and asylees: 2011. Washington: Department of Homeland Security (US); 2012.

Department of Homeland Security (US), Office of Immigration Statistics. Yearbook of immigration statistics: 2011: table 13 [cited 2013 Mar 22]. Available from: URL: https://www.dhs.gov/yearbook-immigration-statistics-2011-0

Nguyen GT Altshuler M . Vaccine-preventable diseases and foreign-born populations. Prim Care 2011; 38:633–42.

Measles outbreak associated with an arriving refugee—Los Angeles County, California, August-September 2011 MMWR Morb Mortal Wkly Rep 2012; 61(21):385–9.

U.S.-incurred costs of wild poliovirus infections in a camp with U.S.-bound refugees—Kenya, 2006 MMWR Morb Mortal Wkly Rep 2008; 57(9):232–5.

Barnett ED Christiansen D Figueira M . Seroprevalence of measles, rubella, and varicella in refugees. Clin Infect Dis 2002; 35:403–8.

Greenaway C Dongier P Boivin JF Tapiero B Miller M Schwartzman K . Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees. Ann Intern Med 2007;146: 20–4.

Lifson AR Thai D Hang K . Lack of immunization documentation in Minnesota refugees: challenges for refugee preventive health care. J Immigr Health 2001; 3:47–52.

Meropol SB . Health status of pediatric refugees in Buffalo, NY. Arch Pediatr Adolesc Med 1995; 149:887–92.

Nysse LJ Pinsky NA Bratberg JP Babar-Weber AY Samuel TT Krych EH Seroprevalence of antibody to varicella among Somali refugees. Mayo Clin Proc 2007; 82:175–80.

Rossi C Shrier I Marshall L Cnossen S Schwartzman K Klein MB Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS One 2012; 7:e44611.

Watts DJ Friedman JF Vivier PM Tompkins CE Alario AJ . Immunization status of refugee children after resettlement. Med Health R I 2011; 94:290–3.

Vukshich Oster N Harpaz R Redd SB Papania MJ . International importation of measles virus—United States, 1993–2001. J Infect Dis 2004; 189 Suppl 1:S48–53.

Pub. L. No. 104-208, 110 Stat. 3009-546 (1996).

Office of Refugee Resettlement. 400—refugee resettlement program. 2012 [cited 2013 Jul 27]. Available from: URL: http://www.acf.hhs.gov/programs/orr/resource/400-refugee-resettlement-program

Adachi K Coleman MS de la Motte Hurst C Vargas ML Oladele A Weinberg MS . Costs of, and reimbursement for, vaccines: a case study at the Board of Health Refugee Services in DeKalb County, Georgia. Vaccine 2013; 31:2317–22.

Cost of vaccinating refugees overseas versus after arrival in the United States, 2005 MMWR Morb Mortal Wkly Rep 2008; 57(09):229–32.

Zaffran M Vandelaer J Kristensen D Melgaard B Yadav P Antwi-Agyei KO The imperative for stronger vaccine supply and logistics systems. Vaccine 2013; 31 Suppl 2:B73–80.

UNICEF/Cold Chain and Logistics Task Force. Strengthening cold chain & logistics (CCL) systems: report of meeting on 1 November 2007, UNICEF House, New York [cited 2013 Jul 13]. Available from: URL: http://www.unicef.org/immunization/files/CCL_Mtg_1Nov07_report.pdf

UNICEF. Cold chain and logistics [cited 2013 Jul 13]. Available from: URL: http://www.unicef.org/immunization/index_42071.html

World Health Organization, PATH. Developing a vision for immunization supply systems in 2020: landscape analysis summaries. Seattle: PATH; 2011. Also available from: URL: http://www.path.org/publications/detail.php?i=1964 [cited 2013 Aug 24].

World Health Organization, PATH. Achieving the global vision for future immunization supply and logistics systems: action plans. Seattle: PATH; 2012. Also available from: URL: http://www.path.org/vaccineresources/details.php?i=1513 [cited 2013 Aug 22].

UNICEF. Cold Chain and Logistics Taskforce Workshop; 2009 Nov 2-4; New York [cited 2013 Jul 13]. Available from: URL: http://www.unicef.org/immunization/files/CCL_Workshop_Report_Nov_2009.pdf

UNICEF. Cold chain & logistics system guidance [cited 2013 Jul 12]. Available from: URL: https://sites.google.com/site/cclguidance

Schreiber B Lydon P . The iSCL Hub: a new WHO and UNICEF collaboration on the immunization supply. Presentation at the 6th Global Health Supply Chain Summit; 2013 Nov 18-20; Addis Ababa, London. Also available from: URL: http://ghsc-2013.com/ghsc2013/ppts/track_4/4-4-Benjaminn-iSCL_Hub_-_GHSCS_2013_-_2013_11_14.pdf [cited 2014 May 11].

Raja H . Project Optimize: rethinking the vaccine supply chain. 2012 Feb 21 [cited 2013 Jul 12]. Available from: URL: cmuscm.blogspot.com/2012/02/project-optimize-rethinking-vaccine.html

PATH, World Health Organization. Optimize strategy: 2009–2012. Seattle: PATH; 2009. Also available from: URL: http://www.path.org/publications/detail.php?i=1664 [cited 2013 Jul 12].

PATH, World Health Organization. Outsourcing vaccine supply chain and logistics to the private sector. Seattle: PATH; 2012. Also available from: URL: http://www.path.org/publications/detail.php?i=2215 [cited 2013 Jul 12].

Robertson J McCarney S . Do battery-free solar refrigerators work in low-light conditions? Op.ti.mize 2012;(12):8-10.

Lasher H Tiffay K . Traveling ehxibit highlights supply system innovations. Op.ti.mize 2013;(16):3-5.

GAVI Alliance. GAVI Alliance supply chain strategy: briefing to SAGE: Why is the GAVI Alliance developing an immunization supply chain strategy? 2014 [cited 2014 May 10]. Available from: URL: http://www.who.int/immunization/sage/meetings/2014/april/3_GAVI_immunization_supply_chain_strategy.pdf

McCarney S Zaffran M . Controlled temperature chain: the new term for out of the cold chain. Ferney (France): PATH; 2009.

Bishai DM Champion C Steele ME Thompson L . Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa. Health Aff (Millwood) 2011; 30:1058–64.

Zipursky S Djingarey MH Ronveaux O Tiendrébéogo S . Notes from the field: delivering MenAfriVac using the CTC approach. Op.ti.mize 2013;(15):1-3.

Brigden D . In pictures: delivering MenAfriVac using the CTC approach. Op.ti.mize 2013;(15):13.

PATH, World Health Organization. Taking advantage of the true heat stability of vaccines. Seattle: PATH; 2012. Also available from: URL: http://www.path.org/publications/detail.php?i=2056 [cited 2014 May 11].

PATH. Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes [cited 2014 Apr 23]. Available from: URL: http://www.path.org/vaccineresources/details.php?i=1574

UNICEF. Supplies and logistics—vaccine forecasting [cited 2013 Aug 25]. Available from: URL: http://www.unicef.org/supply/index_55506.html

GAVI. GAVI partners with Vodafone to bolster the supply chain in Africa. 2012 Dec 10 [cited 2013 Aug 25]. Available from: URL: http://www.gavialliance.org/library/news/gavi-features/2012/gavi-partners-with-vodafone-to-bolster-the-supply-chain-in-africa

Meek D Cattell S Robertson J . Is it time to start barcoding vaccine labels? Op.ti.mize 2011;(9):6-8.

Thornton D Mwanyika H Meek D Kreysa U . Tanzania leading the way with barcodes on vaccine packaging. Op.ti.mize 2013;(16):1-3.

Okwo-Bele JM . Integrating immunization with other health interventions for greater impact: the right strategic choice. J Infect Dis 2012; 205 Suppl 1:S4–5.

Wallace AS Ryman TK Dietz V . Experiences integrating delivery of maternal and child health services with childhood immunization programs: systematic review update. J Infect Dis 2012; 205 Suppl 1:S6–19.

Qazi SA Weber M Boschi-Pinto C Cherian T . Global Action Plan for the Prevention and Control of Pneumonia (GAPP)—report of an informal consultation: La Mainaz, Gex, France, 5–7 March 2007. Geneva: World Health Organization; 2008. Also available from: URL: http://whqlibdoc.who.int/publications/2008/9789241596336_eng.pdf [cited 2014 Apr 23].

World Health Organization, UNICEF. Ending preventable child deaths from pneumonia and diarrhoea by 2025—the integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). Geneva: WHO; 2013.

Ricca J Kureshy N LeBan K Prosnitz D Ryan L . Community-based intervention packages facilitated by NGOs demonstrate plausible evidence for child mortality impact. Health Policy Plan 2014; 29:204–16.

Anand A Luman ET O'Connor PM . Building on success—potential to improve coverage of multiple health interventions through integrated delivery with routine childhood vaccination. J Infect Dis 2012; 205 Suppl 1:S28–39.

Partapuri T Steinglass R Sequeira J . Integrated delivery of health services during outreach visits: a literature review of program experience through a routine immunization lens. J Infect Dis 2012; 205 Suppl 1:S20–7.

Schuchat A De Cock KM . The value of science in integration of services. J Infect Dis 2012; 205 Suppl 1:S1–3.

Callréus T . Perceptions of vaccine safety in a global context. Acta Paediatr 2010; 99:166–71.

Nishtar S . Pakistan, politics and polio. Bull World Health Organ 2010; 88:159–60.

Renne E . Perspectives on polio and immunization in Northern Nigeria. Soc Sci Med 2006; 63:1857–69.

Crowcroft NS McKenzie KJ . Inoculating communities against vaccine scare stories. Lancet Infect Dis 2013; 13:564–5.

Larson HJ Smith DM Paterson P Cumming M Eckersberger E Freifeld CC Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect Dis 2013; 13:606–13.

Sutoto GS . Community participation in immunization programme with special reference to family welfare promotion movement (PKK) in Indonesia. In: Nasution AM Wenas K Sunotoredjo P Soemara LH Kaligis B , editors. Vaccine production and immunization programme in South East Asia: its present status and prospects. Proceedings of the 13th SEAMIC Workshop. Minato-ku, Tokyo (Japan): Southeast Asian Medical Information Center; 1986. p. 183–9.

Nasiru SG Aliyu GG Gasasira A Aliyu MH Zubair M Mandawari SU Breaking community barriers to polio vaccination in Northern Nigeria: the impact of a grass roots mobilization campaign (Majigi). Pathog Glob Health 2012; 106:166–71.

Obregón R Chitnis K Morry C Feek W Bates J Galway M Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan. Bull World Health Organ 2009; 87:624–30.

Ward K Chow MYK King C Leask J . Strategies to improve vaccination uptake in Australia: a systematic review of types and effectiveness. Aust N Z J Public Health 2012; 36:369–77.

Thomas RE Russell ML Lorenzetti DL . Systematic review of interventions to increase influenza vaccination rates of those 60 years and older. Vaccine 2010; 28:1684–701.

Pandey P Sehgal AR Riboud M Levine D Goyal M . Informing resource-poor populations and the delivery of entitled health and social services in rural India. JAMA 2007; 298:1867–75.

Patel AR Nowalk MP . Expanding immunization coverage in rural India: a review of evidence for the role of community health workers. Vaccine 2010; 28:604–13.

Pegurri E Fox-Rushby JA Damian W . The effects and costs of expanding the coverage of immunisation services in developing countries: a systematic literature review. Vaccine 2005; 23:1624–35.

Batt K Fox-Rushby JA Castillo-Riquelme M . The costs, effects and cost-effectiveness of strategies to increase coverage of routine immunizations in low- and middle-income countries: systematic review of the grey literature. Bull World Health Organ 2004; 82:689–96.

Ryman TK Dietz V Cairns KL . Too little but not too late: results of a literature review to improve routine immunization programs in developing countries. BMC Health Serv Res 2008; 8:134.

Uskun E Uskun SB Uysalgenc M Yagiz M . Effectiveness of a training intervention on immunization to increase knowledge of primary healthcare workers and vaccination coverage rates. Public Health 2008; 122:949–58.

Brugha RF Kevany JP . Maximizing immunization coverage through home visits: a controlled trial in an urban area of Ghana. Bull World Health Organ 1996; 74:517–24.

Tandon BN Gandhi N Development C . Immunization coverage in India for areas served by the Integrated Child Development Services programme. Bull World Health Organ 1992; 70:461–5.

Kuhn L Zwarenstein M . Evaluation of a village health worker programme: the use of village health worker retained records. Int J Epidemiol 1990; 19:685–92.

Council for International Organizations of Medical Sciences. Vaccine pharmacovigilance [cited 2013 Mar 19]. Available from: URL: http://www.cioms.ch/index.php/vaccine-pharmacovigilance

Department of Health and Human Services (US). Vaccine Adverse Events Reporting System (VAERS) [cited 2013 May 19]. Available from: URL: http://vaers.hhs.gov

Centers for Disease Control and Prevention (US). Vaccine Safety Datalink (VSD) [cited 2013 May 19]. Available from: URL: http://www.cdc.gov/vaccinesafety/Activities/VSD.html

Department of Health and Human Services (US). National Vaccine Advisory Committee. White paper on the United States Vaccine Safety System. Washington: HHS; 2012. Also available from: URL: http://www.hhs.gov/nvpo/nvac/nvac_vswp.pdf [cited 2013 May 9].

Balinska MA . Hepatitis B vaccination and French Society ten years after the suspension of the vaccination campaign: how should we raise infant immunization coverage rates? J Clin Virol 2009; 46:202–5.

Gerber JS Offit PA . Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis 2009; 48:456–61.

Burgess DC Burgess MA Leask J . The MMR vaccination and autism controversy in United Kingdom 1998–2005: inevitable community outrage or a failure of risk communication? Vaccine 2006; 24:3921–8.

Duclos P . A global perspective on vaccine safety. Vaccine 2004; 22:2059–63.

Milstien JB Kaddar M . The role of emerging manufacturers in access to innovative vaccines of public health importance. Vaccine 2010; 28:2115–21.

World Health Organization. WHO Expert Committee on Biological Standardization [cited 2012 Aug 12]. Available from: URL: http://www.who.int/biologicals/expert_committee/en

World Health Organization. Vaccine regulation—further information [cited 2013 Jul 20]. Available from: URL: http://www.who.int/immunization_standards/vaccine_regulation/nra_rp_info/en

World Health Organization. Immunization standards—a system for the prequalification of vaccines for UN supply [cited 2013 Mar 18]. Available from: URL: http://www.who.int/immunization_standards/vaccine_quality/pq_system/en

World Health Organization. Global Advisory Committee on Vaccine Safety, 29–30 November 2006 Wkly Epidemiol Rec 2007; 82:18–24.

Global Advisory Committee on Vaccine Safety (GACVS), WHO Secretariat. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS. Expert Rev Vaccines 2009; 8:705–16.

World Health Organization. Vaccine safety net [cited 2013 Mar 16]. Available from: URL: http://www.who.int/vaccine_safety/initiative/communication/network/vaccine_safety_websites/en/index.html

World Health Organization. Global vaccine safety blueprint. Geneva: WHO; 2011.

World Health Organization. Global vaccine safety blueprint—the landscape analysis. Geneva: WHO; 2012.

Graham JE Borda-Rodriguez A Huzair F Zinck E . Capacity for a global vaccine safety system: the perspective of national regulatory authorities. Vaccine 2012; 30:4953–9.

Olsson S Pal SN Stergachis A Couper M . Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis. Drug Saf 2010; 33:689–703.

Global Advisory Committee on Vaccine Safety, December 2011 Wkly Epidemiol Rec 2012; 87:53–9.

European Centre for Disease Prevention and Control. Narcolepsy in association with pandemic influenza vaccination: a multi-country European epidemiological investigation. Stockholm (Sweden): ECDC; 2012.

Dieleman J Romio S Johansen K Weibel D Bonhoeffer J Sturkenboom M . Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 2011; 343:d3908.

Tapiainen T Bär G Bonhoeffer J Heininger U . Evaluation of the Brighton Collaboration case definition of acute intussusception during active surveillance. Vaccine 2006; 24:1483–7.

Bonhoeffer J Kohl K Chen R Duclos P Heijbel H Heininger U The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine 2002; 21:298–302.

Bonhoeffer J Heininger U Kohl K Chen RT Duclos P Heijbel H Standardized case definitions of adverse events following immunization (AEFI). Vaccine 2004; 22:547–50.

Brighton Collaboration. Brighton Collaboration: immunize safely [cited 2014 May 10]. Available from: URL: https://brightoncollaboration.org/public

Gold MS Gidudu J Erlewyn-Lajeunesse M Law B . Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. Vaccine 2010; 28:4487–98.

Brighton Collaboration. Automatic Brighton Classification (ABC) tool [cited 2014 Apr 23]. Available from: URL: https://brightoncollaboration.org/public/what-we-do/capacity-buidling/abc.html

Council for International Organizations of Medical Sciences/World Health Organization Working Group on Vaccine Pharmacovigilance. Definition and application of terms for vaccine pharmacovigilance. Geneva: WHO; 2012. Also available from: URL: http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=84&codcch=31 [cited 2013 May 19].

World Health Organization Collaborating Centre for International Drug Monitoring. The Uppsala Monitoring Centre: VigiBase™ [cited 2013 Jun 28]. Available from: URL: http://who-umc.org/DynPage.aspx?id=98082&mn1=7347&mn2=7252&mn3=7322&mn4=7326

Lindquist M . VigiBase, the WHO global ICSR database system: basic facts. Ther Innov Reg Sci 2008; 42:409–19.

World Health Organization Collaborating Centre for International Drug Monitoring. Uppsala reports—2014 [cited 2013 Jun 30]. Available from: URL: http://www.who-umc.org/dynpage.aspx?id=105825&mn1=7347&mn2=7259&mn3=7297

Brighton Collaboration. European vaccine safety datalink (EVSD) [cited 2013 May 19]. Available from: URL: https://brightoncollaboration.org/public/what-we-do/data-linkage/datalinks.html

Vaccine.grid. Quantifying vaccine effects [cited 2014 May 11]. Available from: URL: http://vaccinegrid.org/public.html

World Health Organization. Global vaccine safety: technical support and trainings [cited 2013 Jun 28]. Available from: URL: http://www.who.int/vaccine_safety/initiative/tech_support/en

World Health Organization. The Global Vaccine Safety Initiative (GVSI) [cited 2013 Mar 16]. Available from: URL: http://www.who.int/vaccine_safety/initiative/en

Global Advisory Committee on Vaccine Safety, December 2012 Wkly Epidemiol Rec 2013; 88:65–72.

Global Vaccine Safety Initiative. Report of the 1st meeting of the Global Vaccine Safety Initiative, 20–21 November 2012, Hurghada, Egypt [cited 2013 May 17]. Available from: URL: http://www.who.int/vaccine_safety/global_vaccine_safety_initiative_meeting_Hur_nov12_report.pdf

Food and Drug Administration (US). Global regulatory utilization of vaccine safety surveillance (GRUVSS) [cited 2014 May 10]. Available from: URL: http://www.fda.gov/BiologicsBloodVaccines/InternationalActivities/ucm302702.htm

GRiP Network. Global Research in Pediatrics Network [cited 2014 May 11]. Available from: URL: http://www.grip-network.org/index.php/cms/en/home

Dodd CN Romio SA Black S Vellozzi C Andrews N Sturkenboom M International collaboration to assess the risk of Guillain Barré Syndrome following influenza A (H1N1) 2009 monovalent vaccines. Vaccine 2013; 31:4448–58.

Pan American Health Organization. First Pan American Vaccine Safety Summit. Immun Newsl from Pan American Health Organization 2012; 34:1.

Food and Drug Administration (US). CBER-WHO cooperative agreement: innovations in vaccine clinical trials and pharmacovigilance [cited 2013 May 19]. Available from: URL: http://www.fda.gov/BiologicsBloodVaccines/InternationalActivities/ucm342916.htm

Strengthening Pharmaceutical Systems Program. Safety of medicines in sub-Saharan Africa: assessment of pharmacovigilance systems and their performance. Arlington (VA): Management Sciences for Health; 2011.

Donati C Rappuoli R . Reverse vaccinology in the 21st century: improvements over the original design. Ann N Y Acad Sci 2013; 1285:115–32.

Buonaguro L Wang E Tornesello ML Buonaguro FM Marincola FM . Systems biology applied to vaccine and immunotherapy development. BMC Syst Biol 2011; 5:146.

Vezina LP D'Aoust MA Landry N Couture MMJ Charland N Barbeau B Plants as an innovative and accelerated vaccine-manufacturing solution. BioPharm Int 2011; 24(Suppl 5):S27–30.

Cox MM . Recombinant protein vaccines produced in insect cells. Vaccine 2012; 30:1759–66.

Josefsberg JO Buckland B . Vaccine process technology. Biotechnol Bioeng 2012; 109:1443–60.

Liu MA . DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011; 239:62–84.

Pichichero ME . Improving vaccine delivery using novel adjuvant systems. Hum Vaccin 2008; 4:262–70.

Coffman RL Sher A Seder RA . Vaccine adjuvants: putting innate immunity to work. Immunity 2010; 33:492–503.

Jacques P Moens G Desombere I Dewijngaert J Leroux-Roels G Wettendorff M The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population. Vaccine 2002; 20:3644–9.

Smith J Lipsitch M Almond JW . Vaccine production, distribution, access, and uptake. Lancet 2011; 378:428–38.

Simonsen L Kane A Lloyd J Zaffran M Kane M . Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999; 77:789–800.

World Health Organization. Safety of injections: WHO-UNICEF-UNFPA joint statement on the use of auto-disable syringes in immunization services. Geneva: WHO; 1999. Also available from: URL: http://www.who.int/injection_safety/toolbox/Bundling.pdf [cited 2014 May 11].

Kis EE Winter G Myschik J . Devices for intradermal vaccination. Vaccine 2012; 30:523–38.

Giudice EL Campbell JD . Needle-free vaccine delivery. Adv Drug Deliv Rev 2006; 58:68–89.

Kang SM Song JM Kim YC . Microneedle and mucosal delivery of influenza vaccines. Expert Rev Vaccines 2012; 11:547–60.

Prausnitz MR Mikszta JA Cormier M Andrianov AK . Microneedle-based vaccines. Curr Top Microbiol Immunol 2009; 333:369–93.

Kim YC Park JH Prausnitz MR . Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012; 64:1547–68.

Tong NK Beran J Kee SA Miguel JL Sánchez C Bayas JM Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int 2005; 68:2298–303.

De Oliveira LH Danovaro-Holliday MC Matus CR Andrus JK . Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines 2008; 7:345–53.

PATH. World's smartest sticker: vaccine vial monitors flag heat-damaged vaccine [cited 2013 Aug 22]. Available from: URL: http://www.path.org/projects/vaccine_vial_monitor.php

Chen D Kristensen D . Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines 2009; 8:547–57.

Zhang J Pritchard E Hu X Valentin T Panilaitis B Omenetto FG Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proc Natl Acad Sci 2012; 109:11981–6.

Nabel GJ . Designing tomorrow's vaccines. N Engl J Med 2013; 368:551–60.

London School of Hygiene and Tropical Medicine. Vaccine schedules [cited 2014 May 10]. Available from: URL: http://www.vaccine-schedules.com

World Health Organization. The initiative for vaccine research strategic plan 2010–2020. Geneva: WHO; 2010. Also available from: URL: http://whqlibdoc.who.int/hq/2010/WHO_IVB_10.02_eng.pdf [cited 2013 Apr 4].

One Health Initiative. One Health Initiative will unite human and veterinary medicine [cited 2014 May 10]. Available from: URL: http://www.onehealthinitiative.com

Monath TP Arroyo J Miller C Guirakhoo F . West Nile virus vaccine. Curr Drug Targets Infect Disord 2001; 1:37–50.

Sabchareon A Wallace D Sirivichayakul C Limkittikul K Chanthavanich P Suvannadabba S Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 2012; 380:1559–67.

Wan S-W Lin C-F Wang S Chen Y-H Yeh T-M Liu H-S Current progress in dengue vaccines. J Biomed Sci 2013; 20:37.

National Institutes of Health (US). Research Portfolio Online Reporting Tools (RePORT) [cited 2013 May 19]. Available from: URL: http://projectreporter.nih.gov/reporter.cfm

Policy Cures. G-FINDER 2012: neglected disease research and development: a five year review. Sydney (Australia): Policy Cures; 2012. Also available from: URL: http://www.policycures.org/g-finder2012.html [cited2013 May 19].

John E . Fogarty International Center, National Institutes of Health (US). Pathways to global health research—strategic plan 2008–2012. BethesBethesda (MD): John E. Fogarty International Center; 2008.

Coloma J Harris E . From construction workers to architects: developing scientific research capacity in low-income countries. PLoS Biol 2009; 7:e1000156.

Pronker ES Weenen TC Commandeur HR Osterhaus AD Claassen HJ . The gold industry standard for risk and cost of drug and vaccine development revisited. Vaccine 2011; 29:5846–9.

Pronker ES Weenen TC Commandeur H Claassen EHJHM Osterhaus ADME . Risk in vaccine research and development quantified. PLoS One 2013; 8:e57755.

Vandersmissen W . WHO expectation and industry goals. Vaccine 2001; 19:1611–5.

Plahte J . Tiered pricing of vaccines: a win-win-win situation, not a subsidy. Lancet Infect Dis 2005; 5:58–63.

Madharan G Sangha K Phelps C Fryback D Lieu T Martinez RM Ranking vaccines: a prioritization framework: phase I: demonstration of concept and a software blueprint. Washington: National Academies Press; 2012.

Institute of Medicine. Ranking vaccines: a prioritization software tool—phase II: prototype of a decision-support system. Washington: National Academies Press; 2013. Also available from: URL: http://www.iom.edu/Reports/2013/Ranking-Vaccines-A-Prioritization-Software-Tool-Phase-II.aspx [cited 2014 May 11].

Brooks A Nunes JK Garnett A Biellik R Leboulleux D Birkett AJ Aligning new interventions with developing country health systems: target product profiles, presentation, and clinical trial design. Glob Public Health 2012; 7:931–45.

World Health Organization. Pneumococcal conjugate vaccine: part 1: target product profile. 2007 [cited 2014 May 11]. Available from: URL: http://www.who.int/immunization/sage/Parts1and2_TPP_Master_Table_final_draft.pdf

Davis MM Butchart AT Coleman MS Singer DC Wheeler JR Pok A The expanding vaccine development pipeline, 1995–2008. Vaccine 2010; 28:1353–6.

National Institutes of Health (US), National Institute of Allergy and Infectious Diseases. Resources for researchers [cited 2013 May 19]. Available from: URL: http://www.niaid.nih.gov/labsandresources/resources/dmid/Pages/default.aspx

Grace C . Product development partnerships (PDPs): lessons from PDPs established to develop new health technologies for neglected diseases. Bamenda (CaBamenda (Cameroon): Human Development Resource Centre; 2010.

LaForce FM Konde K Viviani S Préziosi MP . The Meningitis Vaccine Project. Vaccine 2007; 25 Suppl 1:A97–100.

Meningococcal disease in countries of the African meningitis belt, 2012—emerging needs and future perspectives. Wkly Epidemiol Rec 2013; 88:129–36.

Kristiansen PA Diomandé F Ba AK Sanou I Ouédraogo AS Ouédraogo R Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis 2013; 56:354–63.

Cutts FT Zaman SM Enwere G Jaffar S Levine OS Okoko JB Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005;365: 1139–46.

Food and Drug Administration (US). FDA collaboration seeks to speed development of pneumococcal vaccines for children in developing countries [press release] 2010 Feb 1 [cited 2013 Jun 28]. Available from: URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2010/ucm199479.htm

Molzon JA Giaquinto A Lindstrom L Tominaga T Ward M Doerr P The value and benefits of the International Conference on Harmonisation to drug regulatory authorities: advancing harmonization for better public health. Clin Pharmacol 2011;89: 503–12.

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH home page [cited 2013 Jul 8]. Available from: URL: http://www.ich.org

Molzon J . The common technical document: the changing face of the New Drug Application. Nat Rev Drug Discov 2003; 2:71–4.

Food and Drug Administration (US). Center for Biologics Evaluation and Research strategic plan FY 2012–2016. Rockville (MD): Department of Health and Human Services (US); 2011. Also available from: URL: http://www.fda.gov/downloads/aboutfda/centersoffices/cber/ucm266867.pdf [cited 2013 Jul 8].

World Health Organization. Immunization standards: WHO prequalified vaccines. Revised 2014 Apr 1 [cited 2013 Jul 10]. Available from: URL: http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en/index.html

Executive summary of meeting on improving vaccine regulatory capacity, December 2007 Wkly Epidemiol Rec 2008; 83:181–4.

World Health Organization. First Afro Vaccine Regulatory Forum (AVAREF); 2006 Sep 19-22; Accra, Ghana. Also available from: URL: http://www.who.int/immunization_standards/vaccine_regulation/final_report_avaref_meeting.pdf?ua=1 [cited 2013 Jul 8].

World Health Organization. Developing Country Vaccine Regulators' Network (DCVRN) [cited 2013 Jul 9]. Available from: URL: http://www.who.int/immunization_standards/vaccine_regulation/dcvrn/en

Southern JA Slamet L Chocarro L . Developing Country Vaccine Regulator's Network: the development of regulatory authorities and the process of post marketing surveillance in developing countries. 2010 [cited 2013 Jul 10]. Available from: URL: http://www.globe-network.org/sites/default/files/documents/public/resources/conferences/2010/the-development-of-regulatory-authorities-and-of-the-process-of-post-marketing-surveillance-in-developing-countries/developing-country-vaccine-regulators-network.pdf

Chocarro L Duclos P Senouci K Southern J . Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups. Expert Rev Vaccines 2011; 10:1265–70.

Maïga D Akanmori BD Chocarro L . Joint reviews and inspections: strategic forms of collaboration for strengthening the regulatory oversight of vaccine clinical trials in Africa. Vaccine 2009; 28:571–5.

Milstien JB Kaddar M Kieny MP . The impact of globalization on vaccine development and availability. Health Aff (Millwood) 2006; 25:1061–9.

Jadhav SS Gautam M Gairola S . Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status. Biologicals 2009; 37:165–8.

Milstien JB Kaddar M . The role of emerging manufacturers in access to innovative vaccines of public health importance. Vaccine 2010; 28:2115–21.

Jadhav S Datla M Kreeftenberg H Hendriks J . The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries. Vaccine 2008; 26:1611–5.

Friede M Palkonyay L Alfonso C Pervikov Y Torelli G Wood D WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer. Vaccine 2011; 29 Suppl 1:A2–7.